Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia: A progress report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 47, Issue 6, 2002, Pages 445-450

  Kohorn, Ernest I ^a  

^a FMB 322 ^*  (United States)

Author keywords

Risk factors; Staging; Trophoblastic cancer; Trophoblastic tumor

Indexed keywords

CANCER RISK; CANCER STAGING; CONFERENCE PAPER; DISEASE CLASSIFICATION; FEMALE; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; PRIORITY JOURNAL; PROBLEM SOLVING; RISK FACTOR; SCORING SYSTEM; TROPHOBLASTIC DISEASE;

EID: 0036087922     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. The trophoblastic tower of Babel: Classification systems for metastatic gestational trophoblastic neoplasia
2. Five years' experience with chemotherapy of metastatic choriocarcinoma and related tumors in women
3. Treatment of metastatic trophoblastic disease: Good and poor prognosis
4. Risk and prognostic factors in trophoblastic neoplasia
5. FIGO Oncology Committee Report
6. The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT)
7. Modified Bagshawe regimen in high risk gestational trophoblastic disease
8. High risk metastatic gestational trophoblastic disease: A new dose intensive multiagent chemotherapeutic regimen
9. Nonmetastatic gestational neoplasia: Controversies in definition and management
10. The new staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment
11. Society of Gynecologic Oncologists Guidelines: For referral to a gynecologic oncologist: Rationale and benefits: Trophoblastic disease
12. Cancer of the cervix
13. ABO blood-groups in trophoblastic neoplasia
14. ABO blood groups in trophoblastic disease
15. Single dose actinomycin-D in the treatment of postmolar trophoblastic disease
16. The management of high risk choriocarcinoma
17. Decentralized management of trophoblastic disase in the United States: Recent trends in patient care